NASDAQ:ENSG - Nasdaq - US29358P1012 - Common Stock - Currency: USD
ENSG gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. ENSG scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ENSG is not valued too expensively and it also shows a decent growth rate. These ratings could make ENSG a good candidate for quality investing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 6.38% | ||
ROE | 16.22% | ||
ROIC | 7.04% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 8.41% | ||
PM (TTM) | 6.99% | ||
GM | 21.31% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.08 | ||
Debt/FCF | 0.77 | ||
Altman-Z | 3.31 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.56 | ||
Quick Ratio | 1.56 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 23.04 | ||
Fwd PE | 18.68 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 40.1 | ||
EV/EBITDA | 16.19 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.19% |
131.78
-0.54 (-0.41%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.19% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 23.04 | ||
Fwd PE | 18.68 | ||
P/S | 1.78 | ||
P/FCF | 40.1 | ||
P/OCF | 21.82 | ||
P/B | 4.12 | ||
P/tB | 4.37 | ||
EV/EBITDA | 16.19 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 6.38% | ||
ROE | 16.22% | ||
ROCE | 9.13% | ||
ROIC | 7.04% | ||
ROICexc | 8.13% | ||
ROICexgc | 8.39% | ||
OM | 8.41% | ||
PM (TTM) | 6.99% | ||
GM | 21.31% | ||
FCFM | 4.43% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.08 | ||
Debt/FCF | 0.77 | ||
Debt/EBITDA | 0.32 | ||
Cap/Depr | 188.07% | ||
Cap/Sales | 3.71% | ||
Interest Coverage | 50.73 | ||
Cash Conversion | 78.47% | ||
Profit Quality | 63.41% | ||
Current Ratio | 1.56 | ||
Quick Ratio | 1.56 | ||
Altman-Z | 3.31 |